nodes	percent_of_prediction	percent_of_DWPC	metapath
Ribavirin—SLC29A1—pancreatic cancer	0.368	1	CbGaD
Ribavirin—SLC28A3—Gemcitabine—pancreatic cancer	0.123	0.448	CbGbCtD
Ribavirin—Cytarabine—Gemcitabine—pancreatic cancer	0.112	0.513	CrCrCtD
Ribavirin—Azacitidine—Gemcitabine—pancreatic cancer	0.106	0.487	CrCrCtD
Ribavirin—SLC29A1—Gemcitabine—pancreatic cancer	0.0818	0.298	CbGbCtD
Ribavirin—SLC29A1—Fluorouracil—pancreatic cancer	0.07	0.255	CbGbCtD
Ribavirin—SLC28A3—Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane—SLC29A1—pancreatic cancer	0.00889	0.301	CbGpPWpGaD
Ribavirin—SLC28A3—Transport of vitamins, nucleosides, and related molecules—SLC29A1—pancreatic cancer	0.0023	0.0778	CbGpPWpGaD
Ribavirin—SLC28A3—islet of Langerhans—pancreatic cancer	0.00168	0.146	CbGeAlD
Ribavirin—NT5C2—islet of Langerhans—pancreatic cancer	0.0014	0.122	CbGeAlD
Ribavirin—SLC28A3—pancreas—pancreatic cancer	0.00118	0.103	CbGeAlD
Ribavirin—IMPDH1—islet of Langerhans—pancreatic cancer	0.00113	0.0986	CbGeAlD
Ribavirin—ENPP1—Defective AMN causes hereditary megaloblastic anemia 1—PRSS1—pancreatic cancer	0.00103	0.0351	CbGpPWpGaD
Ribavirin—SLC28A3—digestive system—pancreatic cancer	0.00101	0.0877	CbGeAlD
Ribavirin—NT5C2—pancreas—pancreatic cancer	0.000981	0.0854	CbGeAlD
Ribavirin—SLC29A1—Fluoropyrimidine Activity—TYMP—pancreatic cancer	0.000962	0.0326	CbGpPWpGaD
Ribavirin—Fludarabine—SLC29A1—pancreatic cancer	0.000902	0.389	CrCbGaD
Ribavirin—ADK—islet of Langerhans—pancreatic cancer	0.000893	0.0778	CbGeAlD
Ribavirin—NT5C2—Nucleotide metabolism—TYMP—pancreatic cancer	0.000856	0.029	CbGpPWpGaD
Ribavirin—NT5C2—digestive system—pancreatic cancer	0.000838	0.073	CbGeAlD
Ribavirin—SLC29A1—Fluoropyrimidine Activity—DPYD—pancreatic cancer	0.000763	0.0259	CbGpPWpGaD
Ribavirin—SLC29A1—islet of Langerhans—pancreatic cancer	0.000761	0.0662	CbGeAlD
Ribavirin—IMPDH1—Nucleotide metabolism—TYMP—pancreatic cancer	0.000698	0.0236	CbGpPWpGaD
Ribavirin—ENPP1—Endochondral Ossification—PTHLH—pancreatic cancer	0.000687	0.0233	CbGpPWpGaD
Ribavirin—ENPP1—Endochondral Ossification—PTCH1—pancreatic cancer	0.000687	0.0233	CbGpPWpGaD
Ribavirin—NT5C2—Nucleotide metabolism—DPYD—pancreatic cancer	0.000679	0.023	CbGpPWpGaD
Ribavirin—ADK—Nucleotide metabolism—TYMP—pancreatic cancer	0.000649	0.022	CbGpPWpGaD
Ribavirin—ADK—pancreas—pancreatic cancer	0.000628	0.0547	CbGeAlD
Ribavirin—Cytarabine—SLC29A1—pancreatic cancer	0.000582	0.25	CrCbGaD
Ribavirin—IMPDH1—Nucleotide metabolism—DPYD—pancreatic cancer	0.000553	0.0187	CbGpPWpGaD
Ribavirin—SLC29A1—pancreas—pancreatic cancer	0.000535	0.0465	CbGeAlD
Ribavirin—ADK—Nucleotide metabolism—DPYD—pancreatic cancer	0.000514	0.0174	CbGpPWpGaD
Ribavirin—SLC28A3—SLC-mediated transmembrane transport—SLC29A1—pancreatic cancer	0.000493	0.0167	CbGpPWpGaD
Ribavirin—SLC29A1—digestive system—pancreatic cancer	0.000457	0.0398	CbGeAlD
Ribavirin—SLC29A1—Fluoropyrimidine Activity—TYMS—pancreatic cancer	0.000435	0.0147	CbGpPWpGaD
Ribavirin—NT5C2—Nucleotide metabolism—TYMS—pancreatic cancer	0.000387	0.0131	CbGpPWpGaD
Ribavirin—ENPP1—Endochondral Ossification—PLAU—pancreatic cancer	0.000374	0.0127	CbGpPWpGaD
Ribavirin—Glucosamine—MMP9—pancreatic cancer	0.000366	0.158	CrCbGaD
Ribavirin—IMPDH1—Nucleotide metabolism—TYMS—pancreatic cancer	0.000315	0.0107	CbGpPWpGaD
Ribavirin—SLC28A3—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000307	0.0104	CbGpPWpGaD
Ribavirin—ADK—Nucleotide metabolism—TYMS—pancreatic cancer	0.000293	0.00993	CbGpPWpGaD
Ribavirin—SLC28A3—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000251	0.00849	CbGpPWpGaD
Ribavirin—Glucosamine—TNF—pancreatic cancer	0.00024	0.104	CrCbGaD
Ribavirin—Adenosine monophosphate—SRC—pancreatic cancer	0.000232	0.0999	CrCbGaD
Ribavirin—SLC29A1—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000229	0.00776	CbGpPWpGaD
Ribavirin—ENPP1—Endochondral Ossification—MMP9—pancreatic cancer	0.000221	0.0075	CbGpPWpGaD
Ribavirin—ENPP1—Endochondral Ossification—VEGFA—pancreatic cancer	0.000199	0.00674	CbGpPWpGaD
Ribavirin—ENPP1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—pancreatic cancer	0.000197	0.00669	CbGpPWpGaD
Ribavirin—SLC28A3—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	0.000186	0.00631	CbGpPWpGaD
Ribavirin—ENPP1—Endochondral Ossification—TGFB1—pancreatic cancer	0.000183	0.00618	CbGpPWpGaD
Ribavirin—ENPP1—Insulin Signaling—TSC2—pancreatic cancer	0.000181	0.00613	CbGpPWpGaD
Ribavirin—ENPP1—Insulin Signaling—PIK3CG—pancreatic cancer	0.00016	0.00541	CbGpPWpGaD
Ribavirin—SLC29A1—Fluoropyrimidine Activity—TP53—pancreatic cancer	0.000144	0.00489	CbGpPWpGaD
Ribavirin—ENPP1—Insulin Signaling—PIK3CD—pancreatic cancer	0.00014	0.00476	CbGpPWpGaD
Ribavirin—SLC29A1—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	0.000139	0.00471	CbGpPWpGaD
Ribavirin—ENPP1—Endochondral Ossification—AKT1—pancreatic cancer	0.000127	0.0043	CbGpPWpGaD
Ribavirin—ENPP1—Disease—PRSS1—pancreatic cancer	0.000122	0.00415	CbGpPWpGaD
Ribavirin—ENPP1—Disease—ZNRF3—pancreatic cancer	0.000122	0.00415	CbGpPWpGaD
Ribavirin—ENPP1—Insulin Signaling—PIK3CB—pancreatic cancer	0.000122	0.00415	CbGpPWpGaD
Ribavirin—ENPP1—Disease—DTX1—pancreatic cancer	0.000111	0.00375	CbGpPWpGaD
Ribavirin—ENPP1—Insulin Signaling—PTEN—pancreatic cancer	0.000106	0.00358	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—PRSS1—pancreatic cancer	0.000103	0.00348	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—PRSS1—pancreatic cancer	0.000103	0.00348	CbGpPWpGaD
Ribavirin—SLC28A3—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	9.47e-05	0.00321	CbGpPWpGaD
Ribavirin—ENPP1—Disease—DTX4—pancreatic cancer	9.28e-05	0.00315	CbGpPWpGaD
Ribavirin—ENPP1—Disease—PPP2R5B—pancreatic cancer	9.03e-05	0.00306	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—ARG2—pancreatic cancer	8.89e-05	0.00301	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—ARG2—pancreatic cancer	8.89e-05	0.00301	CbGpPWpGaD
Ribavirin—ENPP1—Disease—HEY2—pancreatic cancer	8.69e-05	0.00295	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—PRSS1—pancreatic cancer	8.36e-05	0.00283	CbGpPWpGaD
Ribavirin—ENPP1—Disease—HEY1—pancreatic cancer	8.05e-05	0.00273	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—TYMP—pancreatic cancer	7.77e-05	0.00263	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—TYMP—pancreatic cancer	7.77e-05	0.00263	CbGpPWpGaD
Ribavirin—ADK—Metabolism—PRSS1—pancreatic cancer	7.77e-05	0.00263	CbGpPWpGaD
Ribavirin—ENPP1—Insulin Signaling—PIK3CA—pancreatic cancer	7.46e-05	0.00253	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—ARG2—pancreatic cancer	7.25e-05	0.00246	CbGpPWpGaD
Ribavirin—ENPP1—Disease—JAG2—pancreatic cancer	7.14e-05	0.00242	CbGpPWpGaD
Ribavirin—SLC29A1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	7.06e-05	0.00239	CbGpPWpGaD
Ribavirin—ENPP1—Disease—MEN1—pancreatic cancer	7.03e-05	0.00238	CbGpPWpGaD
Ribavirin—ENPP1—Disease—SLC2A2—pancreatic cancer	6.98e-05	0.00237	CbGpPWpGaD
Ribavirin—ENPP1—Insulin Signaling—HRAS—pancreatic cancer	6.9e-05	0.00234	CbGpPWpGaD
Ribavirin—ADK—Metabolism—ARG2—pancreatic cancer	6.74e-05	0.00228	CbGpPWpGaD
Ribavirin—ENPP1—Disease—SHH—pancreatic cancer	6.71e-05	0.00227	CbGpPWpGaD
Ribavirin—ENPP1—Disease—IAPP—pancreatic cancer	6.63e-05	0.00225	CbGpPWpGaD
Ribavirin—ENPP1—Disease—HSPA1B—pancreatic cancer	6.36e-05	0.00216	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—TYMP—pancreatic cancer	6.34e-05	0.00215	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—GLP1R—pancreatic cancer	6.27e-05	0.00212	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—GLP1R—pancreatic cancer	6.27e-05	0.00212	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—DPYD—pancreatic cancer	6.16e-05	0.00209	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—DPYD—pancreatic cancer	6.16e-05	0.00209	CbGpPWpGaD
Ribavirin—ENPP1—Insulin Signaling—AKT1—pancreatic cancer	6.1e-05	0.00207	CbGpPWpGaD
Ribavirin—ADK—Metabolism—TYMP—pancreatic cancer	5.89e-05	0.002	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—SLC2A2—pancreatic cancer	5.85e-05	0.00198	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—SLC2A2—pancreatic cancer	5.85e-05	0.00198	CbGpPWpGaD
Ribavirin—ENPP1—Disease—JAG1—pancreatic cancer	5.69e-05	0.00193	CbGpPWpGaD
Ribavirin—ENPP1—Disease—CD44—pancreatic cancer	5.41e-05	0.00183	CbGpPWpGaD
Ribavirin—ENPP1—Disease—HSPA1A—pancreatic cancer	5.37e-05	0.00182	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—GLP1R—pancreatic cancer	5.11e-05	0.00173	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—DPYD—pancreatic cancer	5.03e-05	0.0017	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—SLC2A2—pancreatic cancer	4.77e-05	0.00162	CbGpPWpGaD
Ribavirin—ADK—Metabolism—GLP1R—pancreatic cancer	4.75e-05	0.00161	CbGpPWpGaD
Ribavirin—ADK—Metabolism—DPYD—pancreatic cancer	4.67e-05	0.00158	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—CD44—pancreatic cancer	4.53e-05	0.00153	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—CD44—pancreatic cancer	4.53e-05	0.00153	CbGpPWpGaD
Ribavirin—ADK—Metabolism—SLC2A2—pancreatic cancer	4.43e-05	0.0015	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—GCG—pancreatic cancer	4.34e-05	0.00147	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—GCG—pancreatic cancer	4.34e-05	0.00147	CbGpPWpGaD
Ribavirin—ENPP1—Disease—SMAD4—pancreatic cancer	4.27e-05	0.00145	CbGpPWpGaD
Ribavirin—ENPP1—Disease—HES1—pancreatic cancer	4.17e-05	0.00141	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—STK11—pancreatic cancer	4.08e-05	0.00138	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—STK11—pancreatic cancer	4.08e-05	0.00138	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—CD44—pancreatic cancer	3.69e-05	0.00125	CbGpPWpGaD
Ribavirin—ENPP1—Disease—TERT—pancreatic cancer	3.65e-05	0.00124	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—GCG—pancreatic cancer	3.54e-05	0.0012	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—TYMS—pancreatic cancer	3.51e-05	0.00119	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—TYMS—pancreatic cancer	3.51e-05	0.00119	CbGpPWpGaD
Ribavirin—ENPP1—Disease—HIF1A—pancreatic cancer	3.49e-05	0.00118	CbGpPWpGaD
Ribavirin—ENPP1—Disease—TSC2—pancreatic cancer	3.49e-05	0.00118	CbGpPWpGaD
Ribavirin—ADK—Metabolism—CD44—pancreatic cancer	3.43e-05	0.00116	CbGpPWpGaD
Ribavirin—ENPP1—Disease—APOE—pancreatic cancer	3.41e-05	0.00116	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—STK11—pancreatic cancer	3.33e-05	0.00113	CbGpPWpGaD
Ribavirin—ADK—Metabolism—GCG—pancreatic cancer	3.29e-05	0.00112	CbGpPWpGaD
Ribavirin—ENPP1—Disease—NOTCH1—pancreatic cancer	3.15e-05	0.00107	CbGpPWpGaD
Ribavirin—ADK—Metabolism—STK11—pancreatic cancer	3.09e-05	0.00105	CbGpPWpGaD
Ribavirin—ENPP1—Disease—EGF—pancreatic cancer	3.04e-05	0.00103	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—TYMS—pancreatic cancer	2.86e-05	0.00097	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—APOE—pancreatic cancer	2.86e-05	0.000968	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—APOE—pancreatic cancer	2.86e-05	0.000968	CbGpPWpGaD
Ribavirin—ENPP1—Disease—PIK3CD—pancreatic cancer	2.71e-05	0.000917	CbGpPWpGaD
Ribavirin—ADK—Metabolism—TYMS—pancreatic cancer	2.66e-05	0.000902	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—PIK3CG—pancreatic cancer	2.58e-05	0.000874	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—PIK3CG—pancreatic cancer	2.58e-05	0.000874	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—PPARG—pancreatic cancer	2.49e-05	0.000843	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—PPARG—pancreatic cancer	2.49e-05	0.000843	CbGpPWpGaD
Ribavirin—Weight increased—Doxorubicin—pancreatic cancer	2.49e-05	0.000261	CcSEcCtD
Ribavirin—Epistaxis—Epirubicin—pancreatic cancer	2.48e-05	0.000261	CcSEcCtD
Ribavirin—Pruritus—Gemcitabine—pancreatic cancer	2.48e-05	0.000261	CcSEcCtD
Ribavirin—Weight decreased—Doxorubicin—pancreatic cancer	2.47e-05	0.00026	CcSEcCtD
Ribavirin—Sinusitis—Epirubicin—pancreatic cancer	2.47e-05	0.00026	CcSEcCtD
Ribavirin—Hyperglycaemia—Doxorubicin—pancreatic cancer	2.47e-05	0.000259	CcSEcCtD
Ribavirin—Diarrhoea—Irinotecan—pancreatic cancer	2.47e-05	0.000259	CcSEcCtD
Ribavirin—Pneumonia—Doxorubicin—pancreatic cancer	2.45e-05	0.000258	CcSEcCtD
Ribavirin—Shock—Docetaxel—pancreatic cancer	2.45e-05	0.000258	CcSEcCtD
Ribavirin—Nervous system disorder—Docetaxel—pancreatic cancer	2.44e-05	0.000257	CcSEcCtD
Ribavirin—Pruritus—Fluorouracil—pancreatic cancer	2.44e-05	0.000257	CcSEcCtD
Ribavirin—Thrombocytopenia—Docetaxel—pancreatic cancer	2.44e-05	0.000256	CcSEcCtD
Ribavirin—Infestation NOS—Doxorubicin—pancreatic cancer	2.44e-05	0.000256	CcSEcCtD
Ribavirin—Infestation—Doxorubicin—pancreatic cancer	2.44e-05	0.000256	CcSEcCtD
Ribavirin—Tachycardia—Docetaxel—pancreatic cancer	2.43e-05	0.000255	CcSEcCtD
Ribavirin—Skin disorder—Docetaxel—pancreatic cancer	2.42e-05	0.000254	CcSEcCtD
Ribavirin—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	2.42e-05	0.000254	CcSEcCtD
Ribavirin—Bradycardia—Epirubicin—pancreatic cancer	2.41e-05	0.000253	CcSEcCtD
Ribavirin—Diarrhoea—Gemcitabine—pancreatic cancer	2.4e-05	0.000252	CcSEcCtD
Ribavirin—Renal failure—Doxorubicin—pancreatic cancer	2.4e-05	0.000252	CcSEcCtD
Ribavirin—Neuropathy peripheral—Doxorubicin—pancreatic cancer	2.39e-05	0.000251	CcSEcCtD
Ribavirin—Dizziness—Irinotecan—pancreatic cancer	2.38e-05	0.00025	CcSEcCtD
Ribavirin—Haemoglobin—Epirubicin—pancreatic cancer	2.38e-05	0.00025	CcSEcCtD
Ribavirin—Stomatitis—Doxorubicin—pancreatic cancer	2.38e-05	0.00025	CcSEcCtD
Ribavirin—Jaundice—Doxorubicin—pancreatic cancer	2.38e-05	0.00025	CcSEcCtD
Ribavirin—Anorexia—Docetaxel—pancreatic cancer	2.37e-05	0.00025	CcSEcCtD
Ribavirin—Rhinitis—Epirubicin—pancreatic cancer	2.37e-05	0.000249	CcSEcCtD
Ribavirin—Urinary tract infection—Doxorubicin—pancreatic cancer	2.37e-05	0.000249	CcSEcCtD
Ribavirin—Conjunctivitis—Doxorubicin—pancreatic cancer	2.37e-05	0.000249	CcSEcCtD
Ribavirin—Hepatitis—Epirubicin—pancreatic cancer	2.36e-05	0.000249	CcSEcCtD
Ribavirin—Haemorrhage—Epirubicin—pancreatic cancer	2.36e-05	0.000249	CcSEcCtD
Ribavirin—Diarrhoea—Fluorouracil—pancreatic cancer	2.36e-05	0.000248	CcSEcCtD
Ribavirin—ENPP1—Disease—PIK3CB—pancreatic cancer	2.36e-05	0.000799	CbGpPWpGaD
Ribavirin—Hypoaesthesia—Epirubicin—pancreatic cancer	2.35e-05	0.000247	CcSEcCtD
Ribavirin—Pharyngitis—Epirubicin—pancreatic cancer	2.35e-05	0.000247	CcSEcCtD
Ribavirin—ENPP1—Disease—PTGS2—pancreatic cancer	2.34e-05	0.000792	CbGpPWpGaD
Ribavirin—Urinary tract disorder—Epirubicin—pancreatic cancer	2.34e-05	0.000245	CcSEcCtD
Ribavirin—Oedema peripheral—Epirubicin—pancreatic cancer	2.33e-05	0.000245	CcSEcCtD
Ribavirin—IMPDH1—Metabolism—APOE—pancreatic cancer	2.33e-05	0.000789	CbGpPWpGaD
Ribavirin—Hypotension—Docetaxel—pancreatic cancer	2.33e-05	0.000245	CcSEcCtD
Ribavirin—Connective tissue disorder—Epirubicin—pancreatic cancer	2.32e-05	0.000244	CcSEcCtD
Ribavirin—Urethral disorder—Epirubicin—pancreatic cancer	2.32e-05	0.000244	CcSEcCtD
Ribavirin—Hepatobiliary disease—Doxorubicin—pancreatic cancer	2.3e-05	0.000242	CcSEcCtD
Ribavirin—Epistaxis—Doxorubicin—pancreatic cancer	2.3e-05	0.000242	CcSEcCtD
Ribavirin—Vomiting—Irinotecan—pancreatic cancer	2.29e-05	0.000241	CcSEcCtD
Ribavirin—Sinusitis—Doxorubicin—pancreatic cancer	2.29e-05	0.00024	CcSEcCtD
Ribavirin—Dizziness—Fluorouracil—pancreatic cancer	2.28e-05	0.00024	CcSEcCtD
Ribavirin—Visual impairment—Epirubicin—pancreatic cancer	2.28e-05	0.000239	CcSEcCtD
Ribavirin—Rash—Irinotecan—pancreatic cancer	2.27e-05	0.000239	CcSEcCtD
Ribavirin—Dermatitis—Irinotecan—pancreatic cancer	2.27e-05	0.000239	CcSEcCtD
Ribavirin—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	2.27e-05	0.000238	CcSEcCtD
Ribavirin—NT5C2—Metabolism—PIK3CD—pancreatic cancer	2.27e-05	0.000768	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—PIK3CD—pancreatic cancer	2.27e-05	0.000768	CbGpPWpGaD
Ribavirin—Headache—Irinotecan—pancreatic cancer	2.26e-05	0.000237	CcSEcCtD
Ribavirin—Insomnia—Docetaxel—pancreatic cancer	2.25e-05	0.000237	CcSEcCtD
Ribavirin—Paraesthesia—Docetaxel—pancreatic cancer	2.24e-05	0.000235	CcSEcCtD
Ribavirin—Erythema multiforme—Epirubicin—pancreatic cancer	2.24e-05	0.000235	CcSEcCtD
Ribavirin—Vomiting—Gemcitabine—pancreatic cancer	2.23e-05	0.000235	CcSEcCtD
Ribavirin—Bradycardia—Doxorubicin—pancreatic cancer	2.23e-05	0.000234	CcSEcCtD
Ribavirin—Dyspnoea—Docetaxel—pancreatic cancer	2.22e-05	0.000233	CcSEcCtD
Ribavirin—Somnolence—Docetaxel—pancreatic cancer	2.21e-05	0.000233	CcSEcCtD
Ribavirin—Rash—Gemcitabine—pancreatic cancer	2.21e-05	0.000233	CcSEcCtD
Ribavirin—Dermatitis—Gemcitabine—pancreatic cancer	2.21e-05	0.000232	CcSEcCtD
Ribavirin—Eye disorder—Epirubicin—pancreatic cancer	2.21e-05	0.000232	CcSEcCtD
Ribavirin—Tinnitus—Epirubicin—pancreatic cancer	2.2e-05	0.000232	CcSEcCtD
Ribavirin—Haemoglobin—Doxorubicin—pancreatic cancer	2.2e-05	0.000231	CcSEcCtD
Ribavirin—Headache—Gemcitabine—pancreatic cancer	2.2e-05	0.000231	CcSEcCtD
Ribavirin—Flushing—Epirubicin—pancreatic cancer	2.19e-05	0.000231	CcSEcCtD
Ribavirin—Cardiac disorder—Epirubicin—pancreatic cancer	2.19e-05	0.000231	CcSEcCtD
Ribavirin—Vomiting—Fluorouracil—pancreatic cancer	2.19e-05	0.000231	CcSEcCtD
Ribavirin—Rhinitis—Doxorubicin—pancreatic cancer	2.19e-05	0.000231	CcSEcCtD
Ribavirin—Dyspepsia—Docetaxel—pancreatic cancer	2.19e-05	0.00023	CcSEcCtD
Ribavirin—Haemorrhage—Doxorubicin—pancreatic cancer	2.19e-05	0.00023	CcSEcCtD
Ribavirin—Hepatitis—Doxorubicin—pancreatic cancer	2.19e-05	0.00023	CcSEcCtD
Ribavirin—Hypoaesthesia—Doxorubicin—pancreatic cancer	2.18e-05	0.000229	CcSEcCtD
Ribavirin—Rash—Fluorouracil—pancreatic cancer	2.18e-05	0.000229	CcSEcCtD
Ribavirin—Dermatitis—Fluorouracil—pancreatic cancer	2.17e-05	0.000228	CcSEcCtD
Ribavirin—Pharyngitis—Doxorubicin—pancreatic cancer	2.17e-05	0.000228	CcSEcCtD
Ribavirin—ADK—Metabolism—APOE—pancreatic cancer	2.17e-05	0.000734	CbGpPWpGaD
Ribavirin—Decreased appetite—Docetaxel—pancreatic cancer	2.16e-05	0.000228	CcSEcCtD
Ribavirin—Headache—Fluorouracil—pancreatic cancer	2.16e-05	0.000227	CcSEcCtD
Ribavirin—Urinary tract disorder—Doxorubicin—pancreatic cancer	2.16e-05	0.000227	CcSEcCtD
Ribavirin—Oedema peripheral—Doxorubicin—pancreatic cancer	2.16e-05	0.000227	CcSEcCtD
Ribavirin—Gastrointestinal disorder—Docetaxel—pancreatic cancer	2.15e-05	0.000226	CcSEcCtD
Ribavirin—Connective tissue disorder—Doxorubicin—pancreatic cancer	2.15e-05	0.000226	CcSEcCtD
Ribavirin—Fatigue—Docetaxel—pancreatic cancer	2.15e-05	0.000226	CcSEcCtD
Ribavirin—Angiopathy—Epirubicin—pancreatic cancer	2.15e-05	0.000225	CcSEcCtD
Ribavirin—Urethral disorder—Doxorubicin—pancreatic cancer	2.14e-05	0.000225	CcSEcCtD
Ribavirin—Nausea—Irinotecan—pancreatic cancer	2.14e-05	0.000225	CcSEcCtD
Ribavirin—Immune system disorder—Epirubicin—pancreatic cancer	2.14e-05	0.000224	CcSEcCtD
Ribavirin—Mediastinal disorder—Epirubicin—pancreatic cancer	2.13e-05	0.000224	CcSEcCtD
Ribavirin—Pain—Docetaxel—pancreatic cancer	2.13e-05	0.000224	CcSEcCtD
Ribavirin—Constipation—Docetaxel—pancreatic cancer	2.13e-05	0.000224	CcSEcCtD
Ribavirin—Chills—Epirubicin—pancreatic cancer	2.12e-05	0.000223	CcSEcCtD
Ribavirin—Arrhythmia—Epirubicin—pancreatic cancer	2.11e-05	0.000222	CcSEcCtD
Ribavirin—Visual impairment—Doxorubicin—pancreatic cancer	2.11e-05	0.000222	CcSEcCtD
Ribavirin—IMPDH1—Metabolism—PIK3CG—pancreatic cancer	2.1e-05	0.000712	CbGpPWpGaD
Ribavirin—ENPP1—Disease—CTNNB1—pancreatic cancer	2.09e-05	0.000709	CbGpPWpGaD
Ribavirin—Alopecia—Epirubicin—pancreatic cancer	2.09e-05	0.00022	CcSEcCtD
Ribavirin—Nausea—Gemcitabine—pancreatic cancer	2.08e-05	0.000219	CcSEcCtD
Ribavirin—Mental disorder—Epirubicin—pancreatic cancer	2.07e-05	0.000218	CcSEcCtD
Ribavirin—Erythema multiforme—Doxorubicin—pancreatic cancer	2.07e-05	0.000217	CcSEcCtD
Ribavirin—Erythema—Epirubicin—pancreatic cancer	2.06e-05	0.000216	CcSEcCtD
Ribavirin—Malnutrition—Epirubicin—pancreatic cancer	2.06e-05	0.000216	CcSEcCtD
Ribavirin—Feeling abnormal—Docetaxel—pancreatic cancer	2.05e-05	0.000216	CcSEcCtD
Ribavirin—Nausea—Fluorouracil—pancreatic cancer	2.05e-05	0.000215	CcSEcCtD
Ribavirin—Eye disorder—Doxorubicin—pancreatic cancer	2.04e-05	0.000215	CcSEcCtD
Ribavirin—Tinnitus—Doxorubicin—pancreatic cancer	2.04e-05	0.000214	CcSEcCtD
Ribavirin—ENPP1—Disease—PTEN—pancreatic cancer	2.04e-05	0.000691	CbGpPWpGaD
Ribavirin—Gastrointestinal pain—Docetaxel—pancreatic cancer	2.04e-05	0.000214	CcSEcCtD
Ribavirin—Cardiac disorder—Doxorubicin—pancreatic cancer	2.03e-05	0.000213	CcSEcCtD
Ribavirin—Flushing—Doxorubicin—pancreatic cancer	2.03e-05	0.000213	CcSEcCtD
Ribavirin—IMPDH1—Metabolism—PPARG—pancreatic cancer	2.03e-05	0.000687	CbGpPWpGaD
Ribavirin—Flatulence—Epirubicin—pancreatic cancer	2.03e-05	0.000213	CcSEcCtD
Ribavirin—Tension—Epirubicin—pancreatic cancer	2.02e-05	0.000212	CcSEcCtD
Ribavirin—Dysgeusia—Epirubicin—pancreatic cancer	2.02e-05	0.000212	CcSEcCtD
Ribavirin—Nervousness—Epirubicin—pancreatic cancer	2e-05	0.00021	CcSEcCtD
Ribavirin—Back pain—Epirubicin—pancreatic cancer	1.99e-05	0.000209	CcSEcCtD
Ribavirin—Angiopathy—Doxorubicin—pancreatic cancer	1.98e-05	0.000209	CcSEcCtD
Ribavirin—Muscle spasms—Epirubicin—pancreatic cancer	1.98e-05	0.000208	CcSEcCtD
Ribavirin—Immune system disorder—Doxorubicin—pancreatic cancer	1.98e-05	0.000208	CcSEcCtD
Ribavirin—NT5C2—Metabolism—PIK3CB—pancreatic cancer	1.98e-05	0.000669	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—PIK3CB—pancreatic cancer	1.98e-05	0.000669	CbGpPWpGaD
Ribavirin—Mediastinal disorder—Doxorubicin—pancreatic cancer	1.97e-05	0.000207	CcSEcCtD
Ribavirin—Abdominal pain—Docetaxel—pancreatic cancer	1.97e-05	0.000207	CcSEcCtD
Ribavirin—Body temperature increased—Docetaxel—pancreatic cancer	1.97e-05	0.000207	CcSEcCtD
Ribavirin—Chills—Doxorubicin—pancreatic cancer	1.96e-05	0.000206	CcSEcCtD
Ribavirin—NT5C2—Metabolism—PTGS2—pancreatic cancer	1.96e-05	0.000663	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—PTGS2—pancreatic cancer	1.96e-05	0.000663	CbGpPWpGaD
Ribavirin—Arrhythmia—Doxorubicin—pancreatic cancer	1.95e-05	0.000205	CcSEcCtD
Ribavirin—ADK—Metabolism—PIK3CG—pancreatic cancer	1.95e-05	0.000662	CbGpPWpGaD
Ribavirin—Vision blurred—Epirubicin—pancreatic cancer	1.94e-05	0.000204	CcSEcCtD
Ribavirin—Alopecia—Doxorubicin—pancreatic cancer	1.93e-05	0.000203	CcSEcCtD
Ribavirin—Mental disorder—Doxorubicin—pancreatic cancer	1.92e-05	0.000201	CcSEcCtD
Ribavirin—Ill-defined disorder—Epirubicin—pancreatic cancer	1.91e-05	0.000201	CcSEcCtD
Ribavirin—Erythema—Doxorubicin—pancreatic cancer	1.9e-05	0.0002	CcSEcCtD
Ribavirin—Malnutrition—Doxorubicin—pancreatic cancer	1.9e-05	0.0002	CcSEcCtD
Ribavirin—Anaemia—Epirubicin—pancreatic cancer	1.9e-05	0.0002	CcSEcCtD
Ribavirin—Agitation—Epirubicin—pancreatic cancer	1.89e-05	0.000199	CcSEcCtD
Ribavirin—ENPP1—Disease—SRC—pancreatic cancer	1.89e-05	0.000641	CbGpPWpGaD
Ribavirin—ADK—Metabolism—PPARG—pancreatic cancer	1.89e-05	0.000639	CbGpPWpGaD
Ribavirin—Flatulence—Doxorubicin—pancreatic cancer	1.88e-05	0.000197	CcSEcCtD
Ribavirin—Tension—Doxorubicin—pancreatic cancer	1.87e-05	0.000196	CcSEcCtD
Ribavirin—Dysgeusia—Doxorubicin—pancreatic cancer	1.86e-05	0.000196	CcSEcCtD
Ribavirin—Malaise—Epirubicin—pancreatic cancer	1.86e-05	0.000195	CcSEcCtD
Ribavirin—Nervousness—Doxorubicin—pancreatic cancer	1.85e-05	0.000194	CcSEcCtD
Ribavirin—Vertigo—Epirubicin—pancreatic cancer	1.85e-05	0.000194	CcSEcCtD
Ribavirin—IMPDH1—Metabolism—PIK3CD—pancreatic cancer	1.85e-05	0.000626	CbGpPWpGaD
Ribavirin—Syncope—Epirubicin—pancreatic cancer	1.85e-05	0.000194	CcSEcCtD
Ribavirin—Leukopenia—Epirubicin—pancreatic cancer	1.84e-05	0.000194	CcSEcCtD
Ribavirin—Back pain—Doxorubicin—pancreatic cancer	1.84e-05	0.000194	CcSEcCtD
Ribavirin—Hypersensitivity—Docetaxel—pancreatic cancer	1.83e-05	0.000193	CcSEcCtD
Ribavirin—Muscle spasms—Doxorubicin—pancreatic cancer	1.83e-05	0.000192	CcSEcCtD
Ribavirin—ENPP1—Disease—STAT3—pancreatic cancer	1.82e-05	0.000618	CbGpPWpGaD
Ribavirin—Palpitations—Epirubicin—pancreatic cancer	1.82e-05	0.000191	CcSEcCtD
Ribavirin—ENPP1—Disease—NRAS—pancreatic cancer	1.82e-05	0.000616	CbGpPWpGaD
Ribavirin—Loss of consciousness—Epirubicin—pancreatic cancer	1.81e-05	0.00019	CcSEcCtD
Ribavirin—Cough—Epirubicin—pancreatic cancer	1.8e-05	0.000189	CcSEcCtD
Ribavirin—Vision blurred—Doxorubicin—pancreatic cancer	1.79e-05	0.000189	CcSEcCtD
Ribavirin—Asthenia—Docetaxel—pancreatic cancer	1.79e-05	0.000188	CcSEcCtD
Ribavirin—Convulsion—Epirubicin—pancreatic cancer	1.78e-05	0.000187	CcSEcCtD
Ribavirin—Hypertension—Epirubicin—pancreatic cancer	1.78e-05	0.000187	CcSEcCtD
Ribavirin—Ill-defined disorder—Doxorubicin—pancreatic cancer	1.77e-05	0.000186	CcSEcCtD
Ribavirin—Pruritus—Docetaxel—pancreatic cancer	1.76e-05	0.000185	CcSEcCtD
Ribavirin—Anaemia—Doxorubicin—pancreatic cancer	1.76e-05	0.000185	CcSEcCtD
Ribavirin—Arthralgia—Epirubicin—pancreatic cancer	1.75e-05	0.000184	CcSEcCtD
Ribavirin—Myalgia—Epirubicin—pancreatic cancer	1.75e-05	0.000184	CcSEcCtD
Ribavirin—Chest pain—Epirubicin—pancreatic cancer	1.75e-05	0.000184	CcSEcCtD
Ribavirin—Agitation—Doxorubicin—pancreatic cancer	1.75e-05	0.000184	CcSEcCtD
Ribavirin—Anxiety—Epirubicin—pancreatic cancer	1.75e-05	0.000184	CcSEcCtD
Ribavirin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	1.74e-05	0.000183	CcSEcCtD
Ribavirin—Discomfort—Epirubicin—pancreatic cancer	1.73e-05	0.000182	CcSEcCtD
Ribavirin—ADK—Metabolism—PIK3CD—pancreatic cancer	1.72e-05	0.000582	CbGpPWpGaD
Ribavirin—Malaise—Doxorubicin—pancreatic cancer	1.72e-05	0.000181	CcSEcCtD
Ribavirin—Dry mouth—Epirubicin—pancreatic cancer	1.71e-05	0.00018	CcSEcCtD
Ribavirin—Vertigo—Doxorubicin—pancreatic cancer	1.71e-05	0.00018	CcSEcCtD
Ribavirin—Syncope—Doxorubicin—pancreatic cancer	1.71e-05	0.00018	CcSEcCtD
Ribavirin—ENPP1—Metabolism—PTEN—pancreatic cancer	1.71e-05	0.000578	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—PTEN—pancreatic cancer	1.71e-05	0.000578	CbGpPWpGaD
Ribavirin—Leukopenia—Doxorubicin—pancreatic cancer	1.7e-05	0.000179	CcSEcCtD
Ribavirin—Diarrhoea—Docetaxel—pancreatic cancer	1.7e-05	0.000179	CcSEcCtD
Ribavirin—ENPP1—Disease—MYC—pancreatic cancer	1.69e-05	0.000574	CbGpPWpGaD
Ribavirin—Confusional state—Epirubicin—pancreatic cancer	1.69e-05	0.000178	CcSEcCtD
Ribavirin—ENPP1—Disease—TGFB1—pancreatic cancer	1.69e-05	0.000573	CbGpPWpGaD
Ribavirin—Palpitations—Doxorubicin—pancreatic cancer	1.68e-05	0.000177	CcSEcCtD
Ribavirin—Anaphylactic shock—Epirubicin—pancreatic cancer	1.68e-05	0.000177	CcSEcCtD
Ribavirin—Oedema—Epirubicin—pancreatic cancer	1.68e-05	0.000177	CcSEcCtD
Ribavirin—Loss of consciousness—Doxorubicin—pancreatic cancer	1.67e-05	0.000176	CcSEcCtD
Ribavirin—Cough—Doxorubicin—pancreatic cancer	1.66e-05	0.000175	CcSEcCtD
Ribavirin—ENPP1—Disease—EGFR—pancreatic cancer	1.66e-05	0.000561	CbGpPWpGaD
Ribavirin—Shock—Epirubicin—pancreatic cancer	1.65e-05	0.000174	CcSEcCtD
Ribavirin—Convulsion—Doxorubicin—pancreatic cancer	1.65e-05	0.000173	CcSEcCtD
Ribavirin—Nervous system disorder—Epirubicin—pancreatic cancer	1.65e-05	0.000173	CcSEcCtD
Ribavirin—Dizziness—Docetaxel—pancreatic cancer	1.65e-05	0.000173	CcSEcCtD
Ribavirin—Thrombocytopenia—Epirubicin—pancreatic cancer	1.64e-05	0.000173	CcSEcCtD
Ribavirin—Hypertension—Doxorubicin—pancreatic cancer	1.64e-05	0.000173	CcSEcCtD
Ribavirin—Tachycardia—Epirubicin—pancreatic cancer	1.64e-05	0.000172	CcSEcCtD
Ribavirin—Skin disorder—Epirubicin—pancreatic cancer	1.63e-05	0.000171	CcSEcCtD
Ribavirin—Hyperhidrosis—Epirubicin—pancreatic cancer	1.62e-05	0.000171	CcSEcCtD
Ribavirin—Arthralgia—Doxorubicin—pancreatic cancer	1.62e-05	0.00017	CcSEcCtD
Ribavirin—Myalgia—Doxorubicin—pancreatic cancer	1.62e-05	0.00017	CcSEcCtD
Ribavirin—Chest pain—Doxorubicin—pancreatic cancer	1.62e-05	0.00017	CcSEcCtD
Ribavirin—Anxiety—Doxorubicin—pancreatic cancer	1.62e-05	0.00017	CcSEcCtD
Ribavirin—IMPDH1—Metabolism—PIK3CB—pancreatic cancer	1.61e-05	0.000546	CbGpPWpGaD
Ribavirin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	1.61e-05	0.000169	CcSEcCtD
Ribavirin—Discomfort—Doxorubicin—pancreatic cancer	1.6e-05	0.000168	CcSEcCtD
Ribavirin—Anorexia—Epirubicin—pancreatic cancer	1.6e-05	0.000168	CcSEcCtD
Ribavirin—IMPDH1—Metabolism—PTGS2—pancreatic cancer	1.6e-05	0.000541	CbGpPWpGaD
Ribavirin—Dry mouth—Doxorubicin—pancreatic cancer	1.59e-05	0.000167	CcSEcCtD
Ribavirin—Vomiting—Docetaxel—pancreatic cancer	1.58e-05	0.000166	CcSEcCtD
Ribavirin—Rash—Docetaxel—pancreatic cancer	1.57e-05	0.000165	CcSEcCtD
Ribavirin—Hypotension—Epirubicin—pancreatic cancer	1.57e-05	0.000165	CcSEcCtD
Ribavirin—Dermatitis—Docetaxel—pancreatic cancer	1.57e-05	0.000165	CcSEcCtD
Ribavirin—Confusional state—Doxorubicin—pancreatic cancer	1.57e-05	0.000165	CcSEcCtD
Ribavirin—ENPP1—Disease—KRAS—pancreatic cancer	1.57e-05	0.00053	CbGpPWpGaD
Ribavirin—Headache—Docetaxel—pancreatic cancer	1.56e-05	0.000164	CcSEcCtD
Ribavirin—Anaphylactic shock—Doxorubicin—pancreatic cancer	1.55e-05	0.000163	CcSEcCtD
Ribavirin—Oedema—Doxorubicin—pancreatic cancer	1.55e-05	0.000163	CcSEcCtD
Ribavirin—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	1.53e-05	0.000161	CcSEcCtD
Ribavirin—Shock—Doxorubicin—pancreatic cancer	1.53e-05	0.000161	CcSEcCtD
Ribavirin—Nervous system disorder—Doxorubicin—pancreatic cancer	1.52e-05	0.00016	CcSEcCtD
Ribavirin—Thrombocytopenia—Doxorubicin—pancreatic cancer	1.52e-05	0.00016	CcSEcCtD
Ribavirin—Insomnia—Epirubicin—pancreatic cancer	1.52e-05	0.00016	CcSEcCtD
Ribavirin—Tachycardia—Doxorubicin—pancreatic cancer	1.52e-05	0.000159	CcSEcCtD
Ribavirin—Skin disorder—Doxorubicin—pancreatic cancer	1.51e-05	0.000159	CcSEcCtD
Ribavirin—Paraesthesia—Epirubicin—pancreatic cancer	1.51e-05	0.000159	CcSEcCtD
Ribavirin—Hyperhidrosis—Doxorubicin—pancreatic cancer	1.5e-05	0.000158	CcSEcCtD
Ribavirin—Dyspnoea—Epirubicin—pancreatic cancer	1.5e-05	0.000157	CcSEcCtD
Ribavirin—ADK—Metabolism—PIK3CB—pancreatic cancer	1.5e-05	0.000507	CbGpPWpGaD
Ribavirin—Somnolence—Epirubicin—pancreatic cancer	1.49e-05	0.000157	CcSEcCtD
Ribavirin—ADK—Metabolism—PTGS2—pancreatic cancer	1.48e-05	0.000503	CbGpPWpGaD
Ribavirin—Anorexia—Doxorubicin—pancreatic cancer	1.48e-05	0.000156	CcSEcCtD
Ribavirin—Nausea—Docetaxel—pancreatic cancer	1.48e-05	0.000155	CcSEcCtD
Ribavirin—Dyspepsia—Epirubicin—pancreatic cancer	1.48e-05	0.000155	CcSEcCtD
Ribavirin—Decreased appetite—Epirubicin—pancreatic cancer	1.46e-05	0.000153	CcSEcCtD
Ribavirin—Hypotension—Doxorubicin—pancreatic cancer	1.45e-05	0.000153	CcSEcCtD
Ribavirin—Gastrointestinal disorder—Epirubicin—pancreatic cancer	1.45e-05	0.000152	CcSEcCtD
Ribavirin—Fatigue—Epirubicin—pancreatic cancer	1.45e-05	0.000152	CcSEcCtD
Ribavirin—ENPP1—Disease—PIK3CA—pancreatic cancer	1.44e-05	0.000487	CbGpPWpGaD
Ribavirin—Constipation—Epirubicin—pancreatic cancer	1.44e-05	0.000151	CcSEcCtD
Ribavirin—Pain—Epirubicin—pancreatic cancer	1.44e-05	0.000151	CcSEcCtD
Ribavirin—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	1.42e-05	0.000149	CcSEcCtD
Ribavirin—Insomnia—Doxorubicin—pancreatic cancer	1.41e-05	0.000148	CcSEcCtD
Ribavirin—Paraesthesia—Doxorubicin—pancreatic cancer	1.4e-05	0.000147	CcSEcCtD
Ribavirin—IMPDH1—Metabolism—PTEN—pancreatic cancer	1.39e-05	0.000472	CbGpPWpGaD
Ribavirin—Dyspnoea—Doxorubicin—pancreatic cancer	1.39e-05	0.000146	CcSEcCtD
Ribavirin—Feeling abnormal—Epirubicin—pancreatic cancer	1.38e-05	0.000145	CcSEcCtD
Ribavirin—Somnolence—Doxorubicin—pancreatic cancer	1.38e-05	0.000145	CcSEcCtD
Ribavirin—Gastrointestinal pain—Epirubicin—pancreatic cancer	1.37e-05	0.000144	CcSEcCtD
Ribavirin—Dyspepsia—Doxorubicin—pancreatic cancer	1.37e-05	0.000144	CcSEcCtD
Ribavirin—Decreased appetite—Doxorubicin—pancreatic cancer	1.35e-05	0.000142	CcSEcCtD
Ribavirin—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	1.34e-05	0.000141	CcSEcCtD
Ribavirin—Fatigue—Doxorubicin—pancreatic cancer	1.34e-05	0.000141	CcSEcCtD
Ribavirin—Urticaria—Epirubicin—pancreatic cancer	1.33e-05	0.00014	CcSEcCtD
Ribavirin—ENPP1—Disease—HRAS—pancreatic cancer	1.33e-05	0.000451	CbGpPWpGaD
Ribavirin—Pain—Doxorubicin—pancreatic cancer	1.33e-05	0.00014	CcSEcCtD
Ribavirin—Constipation—Doxorubicin—pancreatic cancer	1.33e-05	0.00014	CcSEcCtD
Ribavirin—Body temperature increased—Epirubicin—pancreatic cancer	1.33e-05	0.00014	CcSEcCtD
Ribavirin—Abdominal pain—Epirubicin—pancreatic cancer	1.33e-05	0.00014	CcSEcCtD
Ribavirin—ADK—Metabolism—PTEN—pancreatic cancer	1.29e-05	0.000438	CbGpPWpGaD
Ribavirin—Feeling abnormal—Doxorubicin—pancreatic cancer	1.28e-05	0.000135	CcSEcCtD
Ribavirin—Gastrointestinal pain—Doxorubicin—pancreatic cancer	1.27e-05	0.000134	CcSEcCtD
Ribavirin—Hypersensitivity—Epirubicin—pancreatic cancer	1.24e-05	0.00013	CcSEcCtD
Ribavirin—Urticaria—Doxorubicin—pancreatic cancer	1.23e-05	0.00013	CcSEcCtD
Ribavirin—Abdominal pain—Doxorubicin—pancreatic cancer	1.23e-05	0.000129	CcSEcCtD
Ribavirin—Body temperature increased—Doxorubicin—pancreatic cancer	1.23e-05	0.000129	CcSEcCtD
Ribavirin—Asthenia—Epirubicin—pancreatic cancer	1.21e-05	0.000127	CcSEcCtD
Ribavirin—ENPP1—Metabolism—PIK3CA—pancreatic cancer	1.2e-05	0.000408	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—PIK3CA—pancreatic cancer	1.2e-05	0.000408	CbGpPWpGaD
Ribavirin—Pruritus—Epirubicin—pancreatic cancer	1.19e-05	0.000125	CcSEcCtD
Ribavirin—ENPP1—Disease—AKT1—pancreatic cancer	1.17e-05	0.000398	CbGpPWpGaD
Ribavirin—Diarrhoea—Epirubicin—pancreatic cancer	1.15e-05	0.000121	CcSEcCtD
Ribavirin—Hypersensitivity—Doxorubicin—pancreatic cancer	1.15e-05	0.00012	CcSEcCtD
Ribavirin—Asthenia—Doxorubicin—pancreatic cancer	1.12e-05	0.000117	CcSEcCtD
Ribavirin—Dizziness—Epirubicin—pancreatic cancer	1.11e-05	0.000117	CcSEcCtD
Ribavirin—Pruritus—Doxorubicin—pancreatic cancer	1.1e-05	0.000116	CcSEcCtD
Ribavirin—Vomiting—Epirubicin—pancreatic cancer	1.07e-05	0.000112	CcSEcCtD
Ribavirin—Diarrhoea—Doxorubicin—pancreatic cancer	1.06e-05	0.000112	CcSEcCtD
Ribavirin—Rash—Epirubicin—pancreatic cancer	1.06e-05	0.000111	CcSEcCtD
Ribavirin—Dermatitis—Epirubicin—pancreatic cancer	1.06e-05	0.000111	CcSEcCtD
Ribavirin—Headache—Epirubicin—pancreatic cancer	1.05e-05	0.000111	CcSEcCtD
Ribavirin—Dizziness—Doxorubicin—pancreatic cancer	1.03e-05	0.000108	CcSEcCtD
Ribavirin—Nausea—Epirubicin—pancreatic cancer	9.98e-06	0.000105	CcSEcCtD
Ribavirin—Vomiting—Doxorubicin—pancreatic cancer	9.88e-06	0.000104	CcSEcCtD
Ribavirin—NT5C2—Metabolism—AKT1—pancreatic cancer	9.84e-06	0.000333	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—AKT1—pancreatic cancer	9.84e-06	0.000333	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—PIK3CA—pancreatic cancer	9.82e-06	0.000333	CbGpPWpGaD
Ribavirin—Rash—Doxorubicin—pancreatic cancer	9.8e-06	0.000103	CcSEcCtD
Ribavirin—Dermatitis—Doxorubicin—pancreatic cancer	9.79e-06	0.000103	CcSEcCtD
Ribavirin—Headache—Doxorubicin—pancreatic cancer	9.74e-06	0.000102	CcSEcCtD
Ribavirin—Nausea—Doxorubicin—pancreatic cancer	9.23e-06	9.7e-05	CcSEcCtD
Ribavirin—ADK—Metabolism—PIK3CA—pancreatic cancer	9.13e-06	0.000309	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—AKT1—pancreatic cancer	8.02e-06	0.000272	CbGpPWpGaD
Ribavirin—ADK—Metabolism—AKT1—pancreatic cancer	7.46e-06	0.000253	CbGpPWpGaD
